Recall
FDAHealthJuly 2, 2024

Zydus Pharmaceuticals (USA) Inc — Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceutical

⚠️ Cross contamination with other products

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 2, 2024

Nationwide in the USA and Puerto Rico

What's affected?

Product
Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).
Lot code
L300220

Additional details

Lot #: L300220, Exp. 05/31/2025.

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 12720 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.